Exail Technologies thrives on EU defense growth, with a 519% Q1 orders surge. Check out EXALF stock's advanced tech expertise ...

The future of the Ravens' tight end position could hinge on deciding between the top three guys on the depth chart.

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

A month following the NFL draft, teams continue to shape the complexion of rosters with trades, signings, cuts and extensions ...

The Browns are still a long way from answering all of the questions that hang over them. However, they start taking baby ...

There’s been enough buzz around Arch Manning to fill a decade’s worth of highlight reels, and he hasn't even started a full season.